Brief: Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO With TULSA-AI Volume Reduction
10/06/2025 13:56
June 10 (Reuters) - Profound Medical Corp PRN.TO: PROFOUND MEDICAL ANNOUNCES FIRST COMMERCIAL BPH PATIENT TREATMENT USING TULSA-PRO® WITH TULSA-AI® VOLUME REDUCTION Source text: ID:nGNX1PgbYK Further company coverage: PRN.TO ((Reuters.Briefs@thomsonreuters.com;))